Included in the formulation
АТХ:J.07.A.X Other vaccines for the prevention of bacterial infections
Pharmacodynamics:Stimulates the appearance of antibodies to the causative agent of tularemia 20-30 days after administration, provides immunity to tularemia for 5 years.
Pharmacokinetics:Not described.
Indications:It is used to prevent tularemia in a planned manner or according to epidemic indications.
XXI.Z20-Z29.Z23.4 The need for immunization against tularemia
Contraindications:Acute infectious and non-infectious diseases, chronic diseases in the acute stage - vaccinations are given no earlier than 1 month after recovery or remission, pregnancy and lactation, age up to 3 years, individual intolerance.
Carefully:History of hypersensitivity to the introduction of vaccines.
Pregnancy and lactation:Recommendations for FDA - Category C. Contraindicated during pregnancy and lactation.
Dosing and Administration:Nasojno or intradermally, it is single. Revaccination is carried out after 5 years.
The highest daily dose: with dermal administration - 0.1 ml (200 million microbial bodies); with intradermal administration - 0.1 ml (50 million microbial bodies).
The highest single dose: with dermal administration - 0.1 ml (200 million microbial bodies); with intradermal administration - 0.1 ml (50 million microbial bodies).
Side effects:Local manifestations: hyperemia, tenderness at the injection site.
Common reactions: rarely - hyperthermia. Headache.
Allergic reactions.
Overdose:Cases of overdose not described.
Treatment is symptomatic.
Interaction:Clinically significant interactions are not described.
Special instructions:On the procedure for the administration of the drug is noted in a special journal indicating the date of the procedure, the name of the drug, the serial number, the manufacturer's company and the response to the inoculation.